Corline Biomedical AB (OSTO:CLBIO) Cyclically Adjusted Book per Share: kr4.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLBIO Corline Biomedical AB OSTO:CLBIO
43 GF Score
Price kr17.40
GF Value kr4.89
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Corline Biomedical AB Cyclically Adjusted Book per Share?

Corline Biomedical AB OSTO:CLBIO -2.52% 43 Cyclically Adjusted Book per Share is kr4.20 as of Mar. 2026. GuruFocus rates OSTO:CLBIO with a GF Score™ of 43/100 and a GF Value™ of kr4.89 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Corline Biomedical AB's adjusted book value per share for the three months ended in Mar. 2026 was kr3.844. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr4.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Corline Biomedical AB's average Cyclically Adjusted Book Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-23), Corline Biomedical AB's current stock price is kr17.40. Corline Biomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr4.20. Corline Biomedical AB's Cyclically Adjusted PB Ratio of today is 4.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Corline Biomedical AB was 5.04. The lowest was 1.56. And the median was 3.09.


Corline Biomedical AB  (OSTO:CLBIO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Corline Biomedical AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=17.40/4.20
=4.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Corline Biomedical AB was 5.04. The lowest was 1.56. And the median was 3.09.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Corline Biomedical AB Cyclically Adjusted Book per Share Related Terms


Corline Biomedical AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Corline Biomedical AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB Cyclically Adjusted Book per Share Chart

Corline Biomedical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.96 4.15 4.17

Corline Biomedical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.13 4.16 4.15 4.17 4.20

OSTO:CLBIO vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Corline Biomedical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Cyclically Adjusted PB Ratio falls into.


OSTO:CLBIO
43GF Score
Corline Biomedical AB OSTO:CLBIO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corline Biomedical AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corline Biomedical AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.844/133.5600*133.5600
=3.844

Current CPI (Mar. 2026) = 133.5600.

Corline Biomedical AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.173 101.019 4.195
201609 3.073 101.138 4.058
201612 2.957 102.022 3.871
201703 2.721 102.022 3.562
201706 2.566 102.752 3.335
201709 3.180 103.279 4.112
201712 3.066 103.793 3.945
201803 2.947 103.962 3.786
201806 3.886 104.875 4.949
201809 3.491 105.679 4.412
201812 3.388 105.912 4.272
201903 3.205 105.886 4.043
201906 3.695 106.742 4.623
201909 3.583 107.214 4.463
201912 3.459 107.766 4.287
202003 3.313 106.563 4.152
202006 3.163 107.498 3.930
202009 3.037 107.635 3.768
202012 2.791 108.296 3.442
202103 3.596 108.360 4.432
202106 4.448 108.928 5.454
202109 4.352 110.338 5.268
202112 4.292 112.486 5.096
202203 4.252 114.825 4.946
202206 4.293 118.384 4.843
202209 4.384 122.296 4.788
202212 4.401 126.365 4.652
202303 4.449 127.042 4.677
202306 4.362 129.407 4.502
202309 4.370 130.224 4.482
202312 4.342 131.912 4.396
202403 4.264 132.205 4.308
202406 4.072 132.716 4.098
202409 3.932 132.304 3.969
202412 3.549 132.987 3.564
202503 3.423 132.825 3.442
202506 3.290 133.699 3.287
202509 3.153 133.480 3.155
202512 3.660 133.390 3.665
202603 3.844 133.560 3.844

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr4.20 mean?
Corline Biomedical AB (OSTO:CLBIO) has a Cyclically Adjusted Book per Share of kr4.20 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Corline Biomedical AB and its competitors.
Is Corline Biomedical AB's Cyclically Adjusted Book per Share too high?
Corline Biomedical AB's current Cyclically Adjusted Book per Share is kr4.20. Overall, Corline Biomedical AB has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Corline Biomedical AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Corline Biomedical AB's Cyclically Adjusted Book per Share of kr4.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Corline Biomedical AB and its competitors. Corline Biomedical AB's current Cyclically Adjusted Book per Share is kr4.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corline Biomedical AB stock overvalued right now?
Based on GuruFocus' analysis, Corline Biomedical AB (OSTO:CLBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr4.89, compared to a current price of kr17.40 — trading 255.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr4.20. Corline Biomedical AB's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Corline Biomedical AB (OSTO:CLBIO), the current Cyclically Adjusted Book per Share is kr4.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Corline Biomedical AB (OSTO:CLBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of kr17.40 is trading 255.8% above its estimated GF Value™ of kr4.89. GuruFocus considers Corline Biomedical AB to be Significantly Overvalued.

Key valuation signals for OSTO:CLBIO:

  • Cyclically Adjusted Book per Share: kr4.20
  • GF Value™: kr4.89 vs. price of kr17.40 (255.8% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the OSTO:CLBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Corline Biomedical AB Business Description

Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for OSTO:CLBIO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.40
Price
kr4.89
GF Value